Jantarawong, S.; Swangphon, P.; Lauterbach, N.; Panichayupakaranant, P.; Pengjam, Y.
Modified Curcuminoid-Rich Extract Liposomal CRE-SDInhibits Osteoclastogenesis via the Canonical NF-κB Signaling Pathway. Pharmaceutics 2023, 15, 2248.
https://doi.org/10.3390/pharmaceutics15092248
AMA Style
Jantarawong S, Swangphon P, Lauterbach N, Panichayupakaranant P, Pengjam Y.
Modified Curcuminoid-Rich Extract Liposomal CRE-SDInhibits Osteoclastogenesis via the Canonical NF-κB Signaling Pathway. Pharmaceutics. 2023; 15(9):2248.
https://doi.org/10.3390/pharmaceutics15092248
Chicago/Turabian Style
Jantarawong, Sompot, Piyawut Swangphon, Natda Lauterbach, Pharkphoom Panichayupakaranant, and Yutthana Pengjam.
2023. "Modified Curcuminoid-Rich Extract Liposomal CRE-SDInhibits Osteoclastogenesis via the Canonical NF-κB Signaling Pathway" Pharmaceutics 15, no. 9: 2248.
https://doi.org/10.3390/pharmaceutics15092248
APA Style
Jantarawong, S., Swangphon, P., Lauterbach, N., Panichayupakaranant, P., & Pengjam, Y.
(2023). Modified Curcuminoid-Rich Extract Liposomal CRE-SDInhibits Osteoclastogenesis via the Canonical NF-κB Signaling Pathway. Pharmaceutics, 15(9), 2248.
https://doi.org/10.3390/pharmaceutics15092248